The Pill that May Soon Change the Treatment for Diabetes

Though the first drug that mimics the naturally occurring GLP-1 was approved in 2005, it suffered from the major shortfall of being injectable. Later many analogs were made that required far less number of injections. But the best is still yet to come, which is a drug (GLP-1 agonist) in the form of an oral tablet. Once approved it is bound to change the way diabetes is treated. At present, only one oral form called “semaglutide” is under clinical trials.